TOP2A and cancer: Thus inhibiting TDP2 activity would sensitize cancer cells’ to Top2 inhibitors-induced growth inhibition and killing, thereby increasing the therapeutic efficacy and decreasing the toxicity of Top2 inhibitors in cancer treatment.